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Is There an Evidence-based Approach to
TOLL and CAM?
I have two approaches to CAM and therefore to eCAM. First
as an experimental biologist, I would like to see CAM emerge
not as a highly descriptive branch of biomedicine. CAM
as a biomedical pursuit should be driven by imaginative
probing—a search for evidence through endless questioning.
Second, because of my interest in an evolutionary approach,
especially to the mysteries of the immune system, I seek to
search for origins as a way to understand the length and
breadth or vertical and horizontal positions of biomedical
phenomena. The extensiveness in either of the four directions
provides important clues as to underlying explanations that
often serve to strip away the mystique of what are more com-
plex mechanisms in mammals, especially in humans, which
after all is what CAM is all about—its essence. Taking the
question of TOLL as one infinitesimal example of gene pro-
ducts, we can view signaling with respect to CAM but from
the evolutionary position. It was this evolutionary connection
that inspired me to pick up where Seya left off. Actually,
Seya and co-workers (1) have considered evolutionary ques-
tions by examining TOLL in fish. ‘Rainbow trout Oncho-
rhynchus mikiss possess two genes encoding putative
leucine-rich repeat (LRR)-containing proteins similar to
human TLR5. Molecular cloning of these two LRR proteins
suggested the presence of a TLR5-like membrane form
(rtTLR5M) and a soluble form (rtTLR5S). [They] elucidated
the primary structures and the unique combinational functions
of these fish versions of TLR5. Thus, two distinct gene
encodes the TLR5 orthologs in fish, one of which has a con-
sensus intracellular domain (TIR)’.
According to Seya et al.(2), ‘the TLR system (TLRs, TOLL-
like receptors) is essentially a foreign substance-recognition
system. Thus, it is expected that many constituents of CAMs
can be agonists of TLRs, thereby being possible candidates
for oral vaccine adjuvants. Several reports have focused on
the molecular mechanism by which CAMs are effective in
association with TLRs. For example, Platycodon grandi-
florum, a traditional oriental herbal medicine exerts immuno-
stimulatory and antitumor effects. PG, a polysaccharide
isolated from P. grandiflorum, activates macrophages and
induces nitric acid production and mRNA expression of
iNOS. PG-mediated nitric oxide production was sustained in
macrophages by the TLR4 pathway involving NF-kB (3). An
edible fungus used in traditional medicine, Agaricus blazei,
induced expression of IL-12. IL-12 production was induced
by a TLR4-dependent fashion in macrophages. Oral adminis-
tration of Agaricus blazei further enhanced NK activity (4).
The TLR signaling system is involved in the functional fea-
tures of CAMs. If this is the case, functional genomics and pro-
teomics and the comprehension of the cell signaling networks
may substantially contribute to the development of molecular
evidence-based CAM. The potential application of SAGE,
DNA microarrays and the concept of signalosome to CAM
systems may lead to the identification and characterization
of genes and signaling pathways that are involved in CAM
modalities (5)’.
A TOLL Approach to CAM or is it Vice Versa?
According to Kasai et al. (4), Agaricus blazei Murill, an edible
mushroom,shows immunomodulatory and antitumor activities
(6–10). The specific objectives of this investigation were as
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in peripheral blood mononuclear cells (PBMC) stimulated by
A. blazei Murill fraction H (ABH); (ii) to determine the
optimal concentration of ABH required to induce cytokine
production in vitro; (iii) to identify the nature of TLR inte-
racting with ABH on the cell surface; and (iv) to evaluate the
influence of ABH on natural killer (NK) cell activity. In Brazil,
this fungus is used as a traditional medicine for the preven-
tion of cancer, diabetes, hyperlipidemia, arteriosclerosis and
chronic hepatitis.
The polysaccharides, proteoglycans, polysaccharide–protein
complexes, glycoproteins and steroids from A. blazei Murill
mycelia and fruiting body extracts possess antitumor cytotoxic
activities (8–15). However, the mechanisms of the antitumor
functions of these mushroom components have yet to be
determined. The bacterial lipopolysaccharide, mycoplasma
lipopeptide (MALP-2), interacts with TOLL-like receptors
(TLRs) and induces cytokine production. Similarly, Dectin-1,
a fungal b-glucan receptor subunit, has been shown to interact
with TLR2 and mediate cell activation (16,17). A. blazei
extract was shown to induce cytokine (IL-12) gene expression.
Based on these observations, the authors hypothesized that
ABH may interact with TLRs and induce signals for IL-12
production.
In a similar approach, Yoon et al. (18) looked for a TLR-4-
dependent activation of macrophages by polysaccharide
isolated from the radix Platycodon grandiflorum.‘ Platycodon
grandiflorum is a traditional oriental herbal medicine known to
have immunostimulatory and antitumor effects. PG, a polysac-
charide isolated from P. grandiflorum activates macrophages
and B cells. [They] investigated the membrane receptor and
intracellular signaling responsible for the activation of macro-
phages by PG. Taken together, their results suggest that PG-
medicated induction of nitric oxide production and iNOS
mRNA expression in macrophages is mediated, at least in
part, by TLP4/NF-kappa B signaling pathway’.
Evolutionary Perspectives
TOLL in a Protostome Invertebrate: Mosquito
During the latter part of the 20th century, the discovery of
mammalian TLRs, homologs of insect TOLL receptors, linked
innate and adaptive immunity. This was the first instance that
an immune pathway discovered outside of mammals could
be superimposed onto the human immune system, thus unify-
ing aspects of evolution of immune competence. In their study
on mosquitoes, Christophides et al. (19) have identified 242
Anopheles gambiae genes from 18 gene families implicated
in innate immunity and have detected marked diversification
relative to Drosophila melanogaster. Immune-related gene
families involved in recognition, signal modulation and
effector systems show a marked deficit of orthologs and
excessive gene expansions, possibly reflecting selection pres-
sures from different pathogens encountered in these insects’
very different lifestyles. In contrast, the multifunctional
TOLL signal transduction pathway is substantially conserved,
presumably because of counter selection for developmental
stability. Representative expression profiles confirm that
sequence diversification is accompanied by specific responses
to different immune challenges. Alternative RNA splicing may
also contribute to the expansion of the immune repertoire.
TOLL/IL-1 in Innate Immunity of Nematode Worm
There are entire sequences of genomes from several
invertebrates (e.g. the fruitfly Drosophila, the nematode
Caenorhabditis elegans, the tunicate Ciona, the mosquito
Anopheles). In addition, there are established roles of JAK/
STAT signaling in Drosophila immune responses (20,21).
Genetic and functional genomic approaches have begun to
define the molecular determinants of pathogen resistance in
C. elegans (22). For resistance to pathogens, conserved signal
transduction components are required and these include a
TOLL/IL-1 receptor (TIR) domain adaptor protein that func-
tions upstream of a conserved p38 MAP kinase pathway.
This pathway may be an ancestral innate immune signaling
pathway found in a putative common ancestor of nematodes,
arthropods and even vertebrates. Furthermore, it probably
predated the involvement of the well known TOLL sig-
naling pathways in innate immunity. Pathogen resistance
in C. elegans offers fertile opportunities for continuous
probing into evolutionary and mechanistic insights of signal
transduction and function in innate immunity.
Invertebrates (Earthworms) Recognize Pathogens
by Germ Line Receptors but there is Yet no
Apparent TOLL
According to Engelmann et al. (23), ‘Earthworm innate
immunity depends upon small and large leukocytes (coelomo-
cytes) that synthesize and secrete humoral antimicrobial
molecules (e.g. lysenin, fetidin, eiseniapore, coelomic cyto-
lytic factor [CCF]; Lumbricin I). Small coelomocytes (cyto-
toxic) are positive (CD11a, CD45RA, CD45RO, CDw49b,
CD54, b2-m and Thy-1 [CD90]; CD24; TNF-a) but negative
using other mammalian markers. Large coelomocytes (phago-
cytic) are uniformly negative. Specific earthworm anti-EFCC
1, 2, 3, 4 mAbs are negative for Drosophila melanogaster
hemocytes and mammalian cells but positive those of earth-
worms. Coelomocytes contain several lysosomal enzymes
involved in phagocytosis and a pattern recognition molecule
(CCF) that may trigger the prophenoloxidase cascade a
crucial innate immune response. Earthworms and other inver-
tebrates possess natural, non-specific, non-clonal, and non-
anticipatory immune response governed by germ line genes.
TOLL and TOLL-like receptor signaling is essential for
phagocytosis and antimicrobial peptide synthesis and secretion
in insects and vertebrates but has not yet been shown to be
essential in earthworm innate responses’.
In multicelluar organisms, the phagocytic response plays a
major role in immune mechanisms against environmental
pathogens and in clearance of apoptotic cells. The innate
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structures or products of microbial metabolism [pathogen-
associated molecular patterns (PAMPs)] through a set of
germ line encoded receptors called pattern recognition recept-
ors (PRRs). The PRRs of the innate immune system, par-
ticularly the family of TLRs is responsible for initiating
inflammatory responses against invading pathogens. TOLL
and TLRs signaling is essential for phagocytosis and antimi-
crobial peptide production in insects and vertebrates (24–28).
TLR is also present in the nematode worm C. elegans; how-
ever, antimicrobial peptide expression is independent from
TOLL pathway (29). The point of this review therefore is to
present some of the recent characteristics of the innate cellular
response in earthworms (annelid worms), a complement to
humoral immune functions as summarized in the review by
Cooper et al. (30). Earthworms possess a pattern recognition
molecule (CCF), which may trigger the prophenoloxidase
cascade (29,31), a crucial innate response, and an impressive
array of other innate responses, but TOLL-like proteins have
not yet been discovered.
Vertebrate Ancestors: The Tunicates Typical
Deuterostomes
According to a multiauthored effort (32), the first chordates
appear in the fossil records at the time of the Cambrian explo-
sion, nearly 550 million years ago. The modern ascidian tad-
pole represents a plausible approximation to these ancestral
chordates. Therefore, to explain the origins of chordates
and vertebrates, Paramvir et al. (32) generated a draft of the
protein-coding portion of the genome of the common asci-
dian, Ciona intestinalis. The Ciona genome contains
 16000 protein-coding genes, similar to that of other inver-
tebrates, but only half that found in vertebrates. Vertebrate
gene families are typically found in simplified form in Ciona,
suggesting that ascidians contain the basic ancestral comple-
ment of genes involved in cell signaling and development.
Although there is no evidence of adaptive immunity, a
search of the Ciona genome reveals a variety of genes that
are likely to mediate innate immunity. There are a large
number of possible complement genes, including C1q-like
and C6-like genes, three TLR genes and a variety of lectin
genes. No interleukin or interleukin-receptor genes were iden-
tified except for an IL-1 receptor and an IL-17 receptor gene. It
is possible that Ciona has evolved distinctive innate-immunity
genes, because a search for the protein domains found in ver-
tebrate innate-immunity genes identified a number of Ciona
genes that contain these domains in previously unknown com-
binations. Despite this somewhat negative information, there
is evidence of lytic activity in numerous invertebrates that
destroy experimental targets (30).
Azumi et al. (33) proposed that the mammalian genome
encodes several TLRs, with each TLR responsible for detect-
ing corresponding pathogen-associated molecular patterns
(34). The Ciona genome has only three TLR genes, character-
ized by the extracellular leucine-rich repeat (LRR) motif and
the intracellular TIR domain. The genes involved in the TLR
signaling pathway have been identified, including MyD88,
characterized by the TIR and Death domains, IRAK (IL-1
receptor-associated kinase), TRAF (TNF receptor-associated
factor), NFB and IB. Mouse RP105protein is an atypicalmem-
ber of the mammalianTLR family as it possesses only multiple
LRR motifs and no TIR domain. Ten gene models with domain
architecture similar to that of RP105 have been identified. As
LRR is a motif that also functions in protein–protein interac-
tions and is involved in cell–cell communication, it is conceiv-
able that some of the LRR-containing Ciona genes actually
encode cell-adhesion molecules and not pathogen-recognizers.
Receptors and External Agents that can Affect
the Immune System
Innate Sensing from the Perspective of NK Cells
In a recent commentary by Cooper (35), CAM was viewed
with respect to NK cells. According to Medzhitov and Janeway
(36), the survival of multicellular organisms is dependent on
their ability to recognize invading microbial pathogens and
to induce several immune reactions. Recent evidence suggests
that an evolutionally ancient family of TLRs plays a crucial
role in the detection of microbial infection and the induction
of immune and inflammatory responses. According to Beutler
et al. (37), in humans, innate immune sensing usually proceeds
through the activation of 10 TLRs, which in turn leads to the
production of cytokine mediators that create the inflammatory
milieu and abet the development of an adaptive immune
response.
Each TLR senses a different molecular component of
microbes that have invaded the host. TLR4 senses bacterial
endotoxins (lipopolysaccharide); TLR9 senses unmethylated
DNA, and TLR3 senses double-stranded RNA. Each receptor
has a conserved signaling element called the TIR (TIR/resist-
ance) motif that transduces a signal through five cytoplasmic
adapter proteins, each of which has a homologous motif. The
integration of signals that the receptors emit is a key mechan-
ism that requires resolution with respect to TLRs. By creating
random germ line mutations in mice and screening for indi-
vidual animals with differences in signaling potential, the
complex biochemical circuitry of the innate immune response
can be unraveled. Currently, more than 35000 germ line
mutants have been produced, and  20000 have been screened
to predict innate immunodeficiency states (37).
How do CAM Agents Activate NK Cells?
Takeda and Okumura (38) have recently reviewed CAM and
NK cells and asked the question are Toll-like receptors
involved? According to them Toll-like receptors (TLRs) func-
tion as the pattern-recognition receptors in mammals and play
an essential role in their recognition of microbial and fungal
components. Ten members of the TLR family have been iden-
tified in humans. TLRs activate NK-kB and other signalling
eCAM 2006;3(1) 135pathways, which results in the secretion of various inflammat-
ory cytokines. It has been reported that TLR-2/6 recognize
some components of zymosan, but not ß-glucan, which result
in production of cytokines and chemokines. Thus, TLRs might
play important roles in the biological effects of some intake-
type CAM agents. This is a very interesting subject for further
studies.
TLRs function as the pattern-recognition receptors in
mammals and play an essential role in their recognition of
microbial and fungal components (39–42). Ten members of
the TLR family have been identified in humans. TLRs activate
NK-kB and other signaling pathways, which results in the
secretion of various inflammatory cytokines (39–43). There
is also a report that TOLL-like receptors is recruited to macro-
phage phagosomes and discriminates between pathogens (44).
It has been reported that TLR-2/6 recognize some components
of zymosan, but not b-glucan, which result in production
of cytokines and chemokines (45,46). Thus, TLRs might
play important roles in the biological effects of some intake-
type CAM agents. This is a very interesting subject for further
studies.
Mechanisms by Which Foods Influence
Immune Functions
According to Kaminogawa and Nanno (46), ‘Probiotics inges-
ted may be partially digested in the gut and incorporated into
M cells present in FAE, and then captured by dendritic cells
or macrophages in the interfollicular area of PPs. These profes-
sional phagocytic cells hold various receptors on their surface
capable of binding common structures of microbes, the
pathogen-associated molecular patterns (PAMPs). Among the
receptors for PAMPs, molecular structure and functions of
TLRs (TOLL-like receptors) have been recently unveiled.
Ten TLR families (TLR1–TLR10) have been identified and
ligands recognized by some TLRs have been determined.
TLR2 recognizes peptidoglycans and lipopeptides as TLR4
does lipoteichoic acids and lipopolysaccharides. Moreover,
the CpG oligonucleotides universally detected in bacterial
DNA are recognized by TLR9. The signaling response to stim-
uli recognized by TLRs is mainly mediated by an intracellular
adaptor molecule, MyD88 (myeloid differentiation factor 88).
Thereafter, the nuclear transport of NF-B (nuclear factor-B) is
stimulated and de novo synthesis of cytokines is induced (40).
It has been proposed that stimuli through TLR2 activate
both JNK (c-Jun N-terminal kinase) and ERK (extracellular
signal regulated kinase) and induce production of IL-10, while
stimuli through TLR4 activate JNK and induce production of
IL-12 (47)’.
TOLL and CAM: Perspectives
TOLL is universal and has clear evolutionary counterparts
as evidenced by its presence in invertebrates and at least
in fish as a representative of lower vertebrate, thus there
seems to be a dearth of information derived from many
invertebrates and vertebrates. This in a sense is curious and
that absence of evidence most probably indicates that no
investigators have bothered to search. It is highly unlikely
that the genes that control the expression of TOLL have hops-
cotched throughout the animal kingdom making erratic stops
here and there. Another clear indication rings from this com-
mentary concerns the modification of TOLL activities by pro-
ducts usually from plants (48–52) since there is very little
information on modifications caused by natural animal
products (48).
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